59 participants
Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2018-12-04
- Start Date:
- 2008-04-23
- Completion:
- 2017-07-05
Conditions
- Estrogen Receptor-negative Breast Cancer
- HER2-negative Breast Cancer
- Progesterone Receptor-negative Breast Cancer
- Recurrent Breast Cancer
- Stage IV Breast Cancer
- Triple-negative Breast Cancer
Interventions
- DRUG
- BIOLOGICAL